Susceptibility of bacteria found in Xenopus oocytes
| Antibiotic | Bacterial susceptibility (MIC) | |
| Pseudomonas sp. | S. maltophilia | |
| Amikacin | S 4 (5/5) | S 4 (5/5) |
| Amoxicillin/Clavulanic Acid | R ≥ 32 (5/5) | R ≥ 32 (5/5) |
| Amoxicillin | R ≥ 32 (5/5) | R ≥ 32 (5/5) |
| Cefazolin | R (5/5) | R (5/5) |
| Cefixime | R (5/5) | R (5/5) |
| Cefotaxime | R (5/5) | R (5/5) |
| Cefpodoxime | R (5/5) | R (5/5) |
| Ceftazidime | S ≤ 8 (3/5), R (1/5), I 16 (1/5) | S ≤ 8 (5/5) |
| Ceftiofur | R ≥ 8 (5/5) | R ≥ 8 (5/5) |
| Ceftriaxone | R (4/5), I (1/5) | R (4/5), I (1/5) |
| Cefuroxime | R (5/5) | R (5/5) |
| Cefalexin | R ≥ 32 (5/5) | R ≥ 32 (5/5) |
| Chloramphenicol | R ≥ 32 (5/5) | R ≥ 32 (5/5) |
| Ciprofloxacin | S ≤ 0.05 (5/5) | S ≤ 0.05 (5/5) |
| Difloxacin | R (5/5) | R (5/5) |
| Enrofloxacin | R ≥ 2 (2/5), I 1 (3/5) | R ≥ 2 (5/5) |
| Gentamicin | R ≥ 16 (5/5) | R ≥ 16 (5/5) |
| Imipenem | S (5/5) | S (5/5) |
| Marbofloxacin | R (2/5), I (3/5) | R (4/5), I (1/5) |
| Ofloxacin | R (3/5), I (2/5) | R (5/5) |
| Orbifloxacin | R (5/5) | R (5/5) |
| Piperacillin | I 64 (4/5), I 128 (1/5) | I 64 (5/5) |
| Tetracycline | R ≥ 16 (5/5) | R ≥ 16 (5/5) |
| Ticarcillin | R ≥ 256 (5/5) | R ≥ 256 (5/5) |
| Tobramycin | R ≥ 16 (5/5) | R ≥ 16 (5/5) |
| Antibiotic | Bacterial susceptibility (MIC) | |
| Pseudomonas sp. | S. maltophilia | |
| Amikacin | S 4 (5/5) | S 4 (5/5) |
| Amoxicillin/Clavulanic Acid | R ≥ 32 (5/5) | R ≥ 32 (5/5) |
| Amoxicillin | R ≥ 32 (5/5) | R ≥ 32 (5/5) |
| Cefazolin | R (5/5) | R (5/5) |
| Cefixime | R (5/5) | R (5/5) |
| Cefotaxime | R (5/5) | R (5/5) |
| Cefpodoxime | R (5/5) | R (5/5) |
| Ceftazidime | S ≤ 8 (3/5), R (1/5), I 16 (1/5) | S ≤ 8 (5/5) |
| Ceftiofur | R ≥ 8 (5/5) | R ≥ 8 (5/5) |
| Ceftriaxone | R (4/5), I (1/5) | R (4/5), I (1/5) |
| Cefuroxime | R (5/5) | R (5/5) |
| Cefalexin | R ≥ 32 (5/5) | R ≥ 32 (5/5) |
| Chloramphenicol | R ≥ 32 (5/5) | R ≥ 32 (5/5) |
| Ciprofloxacin | S ≤ 0.05 (5/5) | S ≤ 0.05 (5/5) |
| Difloxacin | R (5/5) | R (5/5) |
| Enrofloxacin | R ≥ 2 (2/5), I 1 (3/5) | R ≥ 2 (5/5) |
| Gentamicin | R ≥ 16 (5/5) | R ≥ 16 (5/5) |
| Imipenem | S (5/5) | S (5/5) |
| Marbofloxacin | R (2/5), I (3/5) | R (4/5), I (1/5) |
| Ofloxacin | R (3/5), I (2/5) | R (5/5) |
| Orbifloxacin | R (5/5) | R (5/5) |
| Piperacillin | I 64 (4/5), I 128 (1/5) | I 64 (5/5) |
| Tetracycline | R ≥ 16 (5/5) | R ≥ 16 (5/5) |
| Ticarcillin | R ≥ 256 (5/5) | R ≥ 256 (5/5) |
| Tobramycin | R ≥ 16 (5/5) | R ≥ 16 (5/5) |
Bacterial culture results from 10 samples of affected oocytes. Both P. fluorescens and P. putida (Pseudomonas sp.) had identical bacterial susceptibility. S, susceptible; I, intermediate; R, resistant. Minimum inhibitory concentration (MIC) is represented in micrograms/milliliter. Results without MIC values were performed by disc testing. The numbers in parentheses represent the number of colonies with the indicated susceptibility/the total number of oocyte samples that grew that species of bacteria.